Abrahami D, D'Andrea E, Yin H, Kim SC, et al. Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab 2023 Jul 3. doi: 10.1111/dom.15196.
PMID: 37395339